Geode Capital Management, LLC Bristol Myers Squibb CO Transaction History
Geode Capital Management, LLC
- $1.39 Trillion
- Q2 2025
A detailed history of Geode Capital Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Geode Capital Management, LLC holds 46,176,690 shares of BMY stock, worth $2.14 Billion. This represents 0.15% of its overall portfolio holdings.
Number of Shares
46,176,690
Previous 45,453,231
1.59%
Holding current value
$2.14 Billion
Previous $2.77 Billion
22.89%
% of portfolio
0.15%
Previous 0.22%
Shares
33 transactions
Others Institutions Holding BMY
# of Institutions
2,675Shares Held
1.64BCall Options Held
22.4MPut Options Held
25.4M-
Vanguard Group Inc Valley Forge, PA195MShares$9.03 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.35 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.01 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.39 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.28 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $98.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...